Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.35 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.35 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.33 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.33 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | ARG2 | P78540 | 1/20 | 0.30 |
| ▸ | CNR1 | P21554 | 1/20 | 0.30 |
| ▸ | CNR2 | P34972 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4454284 | 0.97 | — | — | |
| SCHEMBL8372986 | 0.94 | — | — | |
| SCHEMBL31398004 | 0.83 | ALDH1A1 (0.36) | ALDH1A1 | |
| SCHEMBL11048283 | 0.83 | ALDH1A1 (0.36) | ALDH1A1 | |
| SCHEMBL16970183 | 0.75 | — | — | |
| SCHEMBL31040519 | 0.73 | LMNA (0.42) | LMNATSHRALDH1A1HSD17B10MEN1 | |
| SCHEMBL31040516 | 0.73 | LMNA (0.42) | LMNATSHRALDH1A1HSD17B10MEN1 | |
| 1,6-Hexanediol SCHEMBL27785493 | 0.73 | LMNA (0.50) | LMNATSHRALDH1A1HSD17B10MEN1 | |
| SCHEMBL27842210 | 0.73 | — | — | |
| SCHEMBL14763324 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11161807-B2 | Thermo-thickening compounds for non-polar liquid | SORBONNE UNIVERSITE (FR) | 2021-11-02 | — | — | US | disclosed |
| CN-110573598-A | Thermal thickening compound for non-polar liquids | 索邦大学 | 2019-12-13 | — | — | CN | disclosed |
| EP-3551735-A1 | THERMO-THICKENING COMPOUNDS FOR NON-POLAR LIQUID | Sorbonne Universite (FR) | 2019-10-16 | — | — | EP | disclosed |
| WO-2018108916-A1 | THERMO-THICKENING COMPOUNDS FOR NON-POLAR LIQUID | SORBONNE UNIVERSITE (FR) | 2018-06-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11161807-B2 | Thermo-thickening compounds for non-polar liquid | PUF60, NONO, MAPT | LMNA 2571/4885TSHR 3215/4885ALDH1A1 4262/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.